Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Acute Respiratory Viral Infections in Children
Status:
Completed
Trial end date:
2019-01-09
Target enrollment:
Participant gender:
Summary
The international multicenter double-blind placebo-controlled randomized clinical study in
parallel groups.The objective of this study is to obtain additional data on the efficacy and
safety of Ergoferon in the treatment of acute respiratory viral infections (ARVI) in children
aged from 6 months to 6 years old.